GT Biopharma (GTBP) Cash from Investing Activities (2017 - 2024)
GT Biopharma (GTBP) reported Cash from Investing Activities of $1,000 for Q4 2024, down 99.8% from $478,000 a year earlier.
Powered by 
Analysis
GT Biopharma (GTBP) Cash from Investing Activities (2017 - 2024) Analysis & Trends
For FY2024, GT Biopharma posted Cash from Investing Activities of $12.89 million.
- Cash from Investing Activities has a five-year compound annual growth rate of 130.1% (FY2019 to FY2024).
- By year, Cash from Investing Activities came in at -$2.01 million in FY2023, $12.15 million in FY2022 and -$23.04 million in FY2021.
- Five-year quarterly Cash from Investing Activities spans a low of -$6.99 million in Q1 2023 and a high of $7.86 million in Q2 2024.
- Year over year, Cash from Investing Activities gained in two of the last four quarters, with growth averaging 37.0%.
- Per Business Quant data, the three quarters before Q4 2024 came in at -$1,000 (Q3 2024), $7.86 million (Q2 2024) and $5.03 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | GT Biopharma | 8.58 Mn | 8.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 478,000.00 |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 2.66 Mn |
| Mar 31, 2023 | -6.99 Mn |
| Dec 31, 2022 | 7.51 Mn |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 3.53 Mn |
| Dec 31, 2021 | 2.99 Mn |
| Sep 30, 2019 | 200,000.00 |
| Dec 31, 2018 | -32,000.00 |
| Sep 30, 2018 | -2,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Dec 31, 2017 | -4,000.00 |
API Access
GT Biopharma Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();